Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,570 | 353,423 | 366,828 | 158,874 | 0 |
| Marketable Securities | 135,131 | N/A | N/A | N/A | 0 |
| Other current assets | 12,058 | 12,631 | 12,340 | 6,745 | 0 |
| TOTAL | $349,507 | $368,230 | $382,089 | $165,775 | $0 |
| Non-Current Assets | |||||
| PPE Net | 915 | 1,096 | 1,137 | 1,087 | N/A |
| Other Non-Current Assets | 8,269 | 8,771 | 9,201 | 11,751 | 0 |
| TOTAL | $9,184 | $9,867 | $10,338 | $12,838 | $N/A |
| Total Assets | $358,691 | $378,097 | $392,427 | $178,613 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,441 | 7,214 | 2,532 | 629 | 0 |
| Accrued Expenses | 15,662 | 6,920 | 2,696 | 3,052 | 0 |
| TOTAL | $19,103 | $14,134 | $5,228 | $3,681 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 42 | 43 | 44 | 230,681 | 0 |
| TOTAL | $685 | $567 | $533 | $231,185 | $N/A |
| Total Liabilities | $19,788 | $14,701 | $5,761 | $234,866 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,277 | 2,274 | 2,268 | N/A | N/A |
| Common Shares | 4 | 4 | 4 | N/A | 0 |
| Retained earnings | -131,951 | -103,420 | -76,248 | -58,663 | 0 |
| Other shareholders' equity | -40 | 0 | 0 | 0 | 0 |
| TOTAL | $338,903 | $363,396 | $386,666 | $-56,253 | $0 |
| Total Liabilities And Equity | $358,691 | $378,097 | $392,427 | $178,613 | $0 |